Converge Bio raises $25M to bring generative AI drug discovery to every biotech and pharmaceutical company
PR Newswire —
Led by Bessemer Venture Partners, the highly oversubscribed round comes 18 months after founding, following strong commercial traction and scientific results BOSTON, Jan. 13, 2026 /PRNewswire/ -- Converge Bio, the AI platform for accelerated drug discovery and development, announced today...